Silence Therapeutics's market cap is currently $267.82M. The company's EPS TTM is $-0.19; its P/E ratio is ―; Silence Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
